Omniome
Developed DNA sequencing technology for clinical and research applications. Acquired by PacBio in 2021.
Developed DNA sequencing technology for clinical and research applications. Acquired by PacBio in 2021.
Offers genomic testing services to support research and diagnostics in oncology, cardiology, and other fields.
Provides diagnostic solutions for the early detection and management of age-related macular degeneration.
Focused on developing stem cell-based therapies for neurodegenerative diseases and other conditions.
Offered healthcare data analytics and decision-support tools to improve patient outcomes and optimize operations.